Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India - 04/08/21
Doi : 10.1016/j.tracli.2021.05.009
Naveen Bansal a, Manish Raturi b, ⁎ 
, Yashik Bansal c
, Yashik Bansal c a Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
b Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, 248016 Dehradun, Uttarakhand, India
c Department of Microbiology and Immunology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
⁎Corresponding author.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Esquema
© 2021
Société française de transfusion sanguine (SFTS). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 28 - N° 3
P. 296-298 - août 2021 Regresar al número
Artículo precedente
- Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele
- Chunyan Liu, Yun Xue, Mouna Ouchari, Qinan Yin
- Covid 19 vaccination: Latest guidelines on blood donor deferral in India
- B. Bhasker
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.